Test E + Masteron Cutting (12 weeks)
Cutting cycle: 300mg/wk Test E + 400mg/wk Masteron Enanthate (drostanolone). Masteron provides a hardening effect and anti-estrogenic activity.
Concentration over time
| Date | Masteron Enanthate | Testosterone Enanthate |
|---|---|---|
| W1 | 0.00 | 0.00 |
| W1 | 1501.24 | 833.99 |
| W2 | 2295.84 | 1266.32 |
| W3 | 2679.44 | 1492.88 |
| W4 | 2839.24 | 1614.05 |
| W5 | 2876.79 | 1681.25 |
| W6 | 2847.61 | 1720.83 |
| W7 | 3070.61 | 1746.29 |
| W8 | 3170.43 | 1764.56 |
| W9 | 3190.51 | 1779.15 |
| W10 | 3159.33 | 1791.91 |
| W11 | 3095.69 | 1803.74 |
| W12 | 1815.14 |
Protocol summary
Test E + Masteron Cutting (12 weeks) · 12 weeks starting Aug 16, 26
- Testosterone Enanthate — 150.0 mg 2×/week (Mon/Thu), weeks 0–12
- Masteron Enanthate — 200.0 mg 2×/week (Mon/Thu), weeks 0–12
Protocol overview
- Category
- cutting
- Duration
- 12 weeks
- Compounds
- 2
- Tags
- cutting, masteron, drostanolone, hardening
Compounds in this protocol
- Testosterone Enanthate — 150 mg, 2x-per-week
- Masteron Enanthate — 200 mg, 2x-per-week
How to read this protocol
The chart above shows the modeled blood concentration of each compound over the 12-week duration. Each compound accumulates toward steady state (roughly 5 half-lives). The peak-to-trough ratio within each dose interval depends on the injection frequency relative to the half-life.
Use the peak-trough estimator to see predicted levels at any point, or the clearance calculator to estimate washout after the protocol ends. The PCT planner estimates when to start post-cycle therapy.
Educational only. Not medical advice. Concentration values are modeled estimates based on population pharmacokinetics, not predictions of individual blood levels.